Feb 24, 2011 . Fibrex Medical Research & Development GesmbH company .

Sep 2, 2008 . “We are delighted that FX06 has demonstrated efficacy in .

FIBREX Medical Inc. company information, data and profile. Benchmark the business against its key industry competitors.

-company report lead compounds and market researchwelcome ---fibrex medical equityregistered office, brunner strasse Provide analysis data on pharma biotech .

Fibrex Medical Inc. Report Positive Phase II Results for FX06 9/2/2008 6:39:32 AM More. Fibrex Medical Inc. Initiates Phase II Trial Of Treatment For .

FIBREX Medical Inc.-Therapeutic Competitors Report includes a business summary, tabular representation of the number and .

Mar 14, 2011 . FIBREX Medical Inc.-Therapeutic Competitors Report FIBREX Medical Inc.- Therapeutic Competitors Report Report includes a business summary, .

www.pearsonlab.com/catalog/product.asp?majcatid=270. 0. [PDF] FOR IMMEDIATE RELEASE rainer.henning@fibrexmedical.com IKARIA® TO . File Format: PDF/Adobe Acrobat - Quick View

Mar 3, 2011 . Private Equity Hub (peHub) is an interactive forum for the private equity community, which includes venture capitalists, .

File Format: PDF/Adobe Acrobat - Quick View

Sep 5, 2008 . Fibrex Medical, a biopharmaceutical company focalisation on cardiovascular and incitive diseases, proclaimed positive Phase II results for .

Fibrex Medical ★ fibrexmedical.com. . Pharmaceutical Products · Rheumatoid Arthritis · Biomedicine. Add this company to any Website for : Fibrex Medical: .

2009: The exclusive worldwide license to Fibrex Medical's portfolio, known as IK -600X, is acquired, comprising several investigational compounds that are .

Mar 14, 2011 . FIBREX Medical Inc.-Detailed Product Pipeline FIBREX .

Jan 6, 2011 . FIBREX Medical Inc.-Detailed Product Pipeline - FIBREX Medical Inc.-Detailed Product Pipeline report provides up to date insight into .

Jan 17, 2010 . Fibrex Medical Receives Research Grant for Sepsis Treatment - News Information.

Health care industry insiders provide analysis & data on pharma biotech device & diagnostic company strategy & trends. Deals & technology.

FIBREX Medical. Video conference CTR: "This Week in Cardiology" with Dan Atar reporting on results of the F.I.R.E trial (28,3 MB): .

File Format: Microsoft Powerpoint - View as HTML

Jul 1, 2009 . FIBREX Medical Inc. is a development stage bio .

File Format: PDF/Adobe Acrobat - Quick View

Aug 10, 2009 . Ikaria Holdings, Inc. and Fibrex Medical, Inc. today .

Market research report, FIBREX Medical Inc.-Detailed Product Pipeline Market research report published by Life Science Analytics This Industry Analysis .

Fibrex Medical has successfully completed a first dose in man study with its lead product, the anti-inflammatory peptide FX06. FX06 is developed to prevent .

Peter Petzelbauer), University of Vienna Medical School. 2002-2004, Research Associate Fibrex Medical Research & Development GmbH .

May 16, 2006 . Information provided by: Fibrex Medical Research & Development GmbH. ClinicalTrials.gov Identifier: NCT00326976 .

Apr 6, 2006 . (openPR) - FIBREX Medical has successfully completed a first dose in man study with its lead product, the anti-inflammatory peptide FX06. .

Oct 8, 2009 . FIBREX Medical Inc. - Innovative Concepts in Biomedicine: Anti-inflammatory Peptides.

Aug 12, 2005 . Fibrex Medical Research & Development GmbH announces the reception of public funding for the development of a new sepsis therapy.

FIBREX MEDICAL - Page 4. Fibrex.

Sep 2, 2008 . Fibrex Medical, a biopharmaceutical company focusing on cardiovascular and inflammatory diseases, today announced positive Phase II results .

Email Ikaria Acquires Rights To Fibrex' Investigational Compound Portfolio. acquired the exclusive worldwide license to Fibrex Medical's portfolio of .

File Format: PDF/Adobe Acrobat - Quick View

Mar 3, 2010 . Fibrex Medical is a clinical stage bio-pharmaceutical company that develops new . The core competence of Fibrex Medical is the analysis of .

2009: The exclusive worldwide license to Fibrex Medical's portfolio known as IK- 600x is acquired, comprising several investigational compounds that are .

www.pearsondental.com/catalog/product.asp?. Fibrex Medical Initiates Phase II Trial of Treatment for . Oct 9, 2006 . Fibrex Medical Initiates Phase II Trial of Treatment for Reperfusion Injury in Myocardial Infarction. from PR Newswire.

Colby Pharmaceutical Company, Cylene Pharmaceuticals, Dimera Incorporated, DNage , Epeius Biotechnologies Corporation, F2G Limited, Fibrex Medical Inc. .

Description: FIBREX Medical Inc.-Detailed Product Pipeline provides up to date insight into company's business description, product information, .

FIBREX Medical Inc. is a development stage bio-pharmaceutical company. Its operational affiliate FIBREX Medical Research & Development GmbH was established .

May 8, 2011 . FIBREX Medical Inc. is a development stage bio-pharmaceutical company. Its operational affiliate FIBREX Medical Research & Development GmbH .

Mar 16, 2011 . FIBREX Medical Inc. company research & investing information. Find executives and the latest company news.

Aug 10, 2009 . Fibrex Medical will receive upfront and milestone payments, . Fibrex Medical, Inc. is a privately held company headquartered in Cambridge, .

Jul 1, 2009 . FIBREX Medical Inc. - Innovative Concepts in Biomedicine: . the Vienna Business Agency promotion vehicle granted FIBREX Euro 100.000 in .

File Format: PDF/Adobe Acrobat - Quick View

Welcome to dothealth directory the definitive source for finding healthcare companies, products and services from around the world, brought to you by IIR .

Fibrex Medical Receives Research Grant for Sepsis Treatment Main Category: Infectious Diseases / Bacteria / Viruses Article Date: 12 Aug 2005 - 0:00 PDT. .

Petzelbauer and MChE, FIBREX attracted the attention of the scientific community . Today FIBREX Medical Research and Development Inc. is one of the most .

Apr 15, 2011 . FIBREX Medical Inc., Portfolio of Investigational Compounds .

Sitemap